1. CCLHD Research Repositories

Matthew Wong

View Statistics Email Alert RSS Feed

Profile

Loading... 2 0 20 0 false
Credit Name
Matthew Wong
Full Name
Wong, Matthew
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Fulltext:  No Fulltext
Date Issued:  [2020 TO 2024]

Results 1-4 of 4 (Search time: 0.004 seconds).

PreviewIssue DateTitleAuthor(s)
129-Mar-2024Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapseTong, Elissa; Horsley, Patrick; Wheeler, Helen; Wong, Matthew ; Venkatesha, Venkatesha; Chan, Joseph; Kastelan, Marina; Back, Michael 
2Jan-2022Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapyJayamanne, Dasantha ; Wong, Matthew ; Back, Michael ; Metz, G.; Wheeler, H.; Cook, R.; Little, N.; Parkinson, J.; Kastelan, M.; Brown, C.
39-Jun-2021Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastomaCook, Theresa A ; Jayamanne, Dasantha ; Wong, Matthew ; Cove, Nicola ; Back, Michael ; Wheeler, H.; Parkinson, J.; Cook, R. J.; Kastelan, M. A.; Brown, C.
4Mar-2020The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade gliomaWong, Matthew ; Jayamanne, Dasantha ; Back, Michael ; Chan, J.; Wheeler, H.; Khasraw, M.; Kastelan, M.; Guo, L.